Laparoscopy-guided percutaneous microwave ablation for symptomatic 12.8 cm hepatic hemangioma with low blood loss and short hospital stay post-operation: A case report and literature review

2020 ◽  
pp. 1-7
Author(s):  
Hui-Li Zhang ◽  
Hong-Bo Meng ◽  
Xiao-Long Li ◽  
Li-Ping Sun ◽  
Feng Lu ◽  
...  
Keyword(s):  
Mr Imaging ◽  
Blood Loss ◽  
Microwave Ablation ◽  
Vena Cava ◽  
Abdominal Distension ◽  
Left Lobe ◽  
Gastric Body ◽  
Hepatic Hemangioma ◽  
Contrast Enhanced ◽  
Percutaneous Microwave Ablation

We described a patient with symptomatic giant hepatic hemangioma (GHH) treated with laparoscopic guided percutaneous microwave ablation (MWA). A 58 years’ old woman was referred to our hospital who presented with upper abdominal distension and appetite loss for more than 1 year. The medical history included untreated multiple hepatic hemangiomas (HH) that had been detected 13 years ago and hypertension for more than 12 years. Initial laboratory tests revealed D-dimer mild increase and negative tumor markers. Magnetic resonance (MR) imaging demonstrated multiple nodules of different sizes in the liver and the largest lesion was located on the left lobe (longest diameter 12.8 cm), which replaced the whole enlarged left lobe and compressed the gastric body and inferior vena cava. Contrast-enhanced ultrasound (CEUS) and contrast-enhanced MR imaging both showed the typical enhancement pattern of hemangioma and abnormal perfusion was seen in the surrounding liver parenchyma. With the laparoscopy guidance, we performed microwave ablation till the whole tumor was seen atrophy. The total operation duration was 2 hours, with intra-operative blood loss less than 20 ml. The post-operative course was uneventful. The patient was discharged 3 days after the operation. Abdominal distension decreased, appetite improved, blood pressure controlled at normal level after the operation. MR revealed significant volume reduction of the tumor after the operation.

scholarly journals Safety and efficacy of percutaneous microwave ablation for post-procedural haemostasis: a bi-central retrospective study focusing on safety and efficacy

2020 ◽  
Vol 93 (1106) ◽  
pp. 20190615
Author(s):  
Tian’an Jiang ◽  
Alexis Kelekis ◽  
Qiyu Zhao ◽  
Argyro Mazioti ◽  
Jia Liu ◽  
...  
Keyword(s):  
Microwave Ablation ◽  
Treatment Algorithm ◽  
Doppler Imaging ◽  
Percutaneous Ablation ◽  
Technical Success ◽  
Safety And Efficacy ◽  
Contrast Enhanced ◽  
Limited Experience ◽  
Active Extravasation ◽  
Percutaneous Microwave Ablation

Objective: To review safety and efficacy of percutaneous microwave ablation (MWA) for post-procedural haemostasis. Methods: Institutional databases retrospective research identified 10 cases of iatrogenic bleeding who underwent percutaneous MWA for post-procedural haemostasis. Ultrasound examination with Doppler and contrast enhancement identified a source of active bleeding prior to ablation; additionally they were used as guiding modality for antenna insertion whilst, post-ablation, assessed the lack of active extravasation. Target locations included liver intercostal space spleen and thyroid gland. Technical success was defined as positioning of the antenna on the desired location. Treatment end point was considered the disappearance of active extravasation in both Doppler imaging and contrast-enhanced ultrasound. Results: Technical success (i.e. positioning of the antenna on the desired location) was achieved in all cases. No complications were noted. All patients post MWA remained haemodynamically stable with no need for transfusion and were discharged from the hospital the next morning. Imaging and clinical follow-up in all patients before exiting the hospital did not depict any sign of active extravasation or bleeding. Conclusion: Our limited experience reports preliminary data showing that MWA could be added in the armamentarium of percutaneous therapies for iatrogenic bleeding. More prospective studies with larger patient samples are necessary for verification of this technique as well as for drawing broader conclusions in order to evaluate the place of percutaneous ablation in the treatment algorithm of haemorrhage. Advances in knowledge: Percutaneous ablation might have a role in haemostasis in well-selected cases

scholarly journals Congenital hepatic hemangioma presenting with neonatal intestinal obstruction: A case report

2021 ◽  
Vol 10 ◽  
pp. 21
Author(s):  
Sumaira Noor Maham ◽  
Shabbir Ahmad ◽  
Muhammad Jawad Afzal ◽  
Nabila Talat
Keyword(s):  
Intestinal Obstruction ◽  
Abdominal Distension ◽  
Left Lobe ◽  
Jejunal Loop ◽  
Hepatic Hemangioma ◽  
Rare Presentation ◽  
Case Presentation ◽  
Hepatic Mass ◽  
Neonatal Intestinal Obstruction

Background: Congenital hepatic hemangioma usually presents with abdominal distension. Rarely it may cause intestinal obstruction. We present a case of congenital hepatic hemangioma causing neonatal intestinal obstruction. Case Presentation: A 4-day-old neonate presented with clinical and radiological features of neonatal intestinal obstruction. On exploration, a loop of jejunum was found adherent with a hepatic mass, arising from the left lobe of the liver. The hepatic mass profusely bled in an attempt of removing the adherent jejunal loop. Thus, the adherent portion was isolated and jejunojejunal end to end anastomosis was done. The hepatic mass along with an adherent small piece of jejunum was also excised. Histopathology showed hepatic hemangioma. The patient is doing fine on the 10-month follow-up. Conclusion: We report a rare presentation of congenital hepatic hemangioma with neonatal intestinal obstruction. Although the optimum therapy for hepatic hemangioma is medical management, at times, surgical resection becomes a necessary option.

scholarly journals Role of contrast-enhanced ultrasound in evaluating the efficiency of ultrasound guided percutaneous microwave ablation in patients with renal cell carcinoma

2013 ◽  
Vol 47 (4) ◽  
pp. 398-404 ◽  
Author(s):  
Xin Li ◽  
Ping Liang ◽  
Jie Yu ◽  
Xiao-Ling Yu ◽  
Fang-Yi Liu ◽  
...  
Keyword(s):  
Predictive Value ◽  
Renal Cell ◽  
Microwave Ablation ◽  
Contrast Enhanced Ultrasound ◽  
Mri Imaging ◽  
The Third ◽  
Contrast Enhanced ◽  
Sensitivity Specificity ◽  
Percutaneous Microwave Ablation

Abstract Background. The aim of the study was to evaluate the efficiency and feasibility of contrast-enhanced ultrasound (CEUS) with Sonovue in assessing of renal cell carcinomas (RCCs) following ultrasound (US)-guided percutaneous microwave ablation (MWA). Patients and methods. Seventy-nine patients (60 males and 19 females) with 83 lesions (mean size 3.2±1.6 cm) were treated by US-guided percutaneous MWA. The CEUS results of the third day after the ablation were compared with the synchronous contrast-enhanced computed tomography (CT)/magnetic resonance imaging (MRI) results and biopsy pathological results. The follow-up was performed by CEUS and CT/MRI after 1, 3, 6 months and every 6 months subsequently. The combination of clinical follow-up results and CT/MRI imaging findings was the reference standard of CEUS results for evaluating the therapeutic effect. The identification of residual or recurrence tumour was assessed by two blinded radiologists. Results. On the third day after MWA, CEUS showed 68 of 83 lesions (68/83, 81.9%) successfully ablated and 15 of 83 (18.1%) with residual tumours. Among residual tumours, 13 (86.7%) were confirmed by contrast-enhanced CT/MRI findings and biopsy results. The sensitivity, specificity, accuracy, positive and negative predictive value of CEUS evaluating the short-term MWA effectiveness were 100%, 97.1%, 97.6%, 86.7% and 100%, respectively. During the six years follow-up (median 26 months), the CEUS showed recurrence in 7 patients, and six of them achieved consistent results on CEUS and CT/MRI imaging. The sensitivity, specificity, accuracy, positive and negative predictive value for CEUS evaluating long-term MWA effectiveness were 85.7%, 98.7%, 97.6%, 85.7% and 98.7%, respectively. Conclusions. The post-procedural CEUS demonstrated as an effective and feasible method in evaluating a therapeutic effect of RCCs following MWA.

Preoperative Percutaneous Microwave Ablation of Long Bone Metastases Using a Parallel Medullary Approach for Reduction of Operative Blood Loss

2017 ◽  
Vol 28 (7) ◽  
pp. 1069-1071 ◽  
Author(s):  
Joshua Cornman-Homonoff ◽  
Zoe A. Miller ◽  
John Smirniotopoulos ◽  
Benjamin J. May ◽  
Ronald S. Winokur ◽  
...  
Keyword(s):  
Blood Loss ◽  
Bone Metastases ◽  
Microwave Ablation ◽  
Long Bone ◽  
Operative Blood Loss ◽  
Percutaneous Microwave Ablation
Sign in / Sign up

Export Citation Format

Share Document